BioCentury
ARTICLE | Clinical News

DPK-060: Phase I/IIa data

December 7, 2009 8:00 AM UTC

Data from the double-blind, placebo-controlled portion of a Phase I/IIa trial in 41 patients showed that twice-daily DPK-060 met the primary endpoint of significantly reducing microbial density in ecz...